Genus plc Stock
The Genus plc stock is trending slightly upwards today, with an increase of €0.20 (0.790%) compared to yesterday's price.
Pros and Cons of Genus plc in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genus plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genus plc | 0.790% | 2.400% | 4.065% | -10.490% | -12.925% | -9.796% | -59.685% |
| Ligand Pharmaceuticals | -1.540% | -3.759% | -7.246% | 118.803% | 54.217% | 316.260% | 167.056% |
| United Therapeutics | -0.520% | -2.019% | -3.756% | 84.880% | 6.740% | 104.989% | 194.258% |
| Ionis Pharmaceuticals Inc. | -1.480% | -5.964% | -34.579% | 21.707% | -32.019% | 27.978% | 47.510% |
Comments
Genus (OTCMKTS:GENSF) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for GENSF provided by MarketBeat